1. Home
  2. RIME vs CHRO Comparison

RIME vs CHRO Comparison

Compare RIME & CHRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RIME
    SELLHOLDBUYas of 2024 years ago
  • CHRO
    SELLHOLDBUYas of 2 days ago
  • Stock Information
  • Founded
  • RIME 1982
  • CHRO 2002
  • Country
  • RIME United States
  • CHRO United States
  • Employees
  • RIME N/A
  • CHRO N/A
  • Industry
  • RIME
  • CHRO
  • Sector
  • RIME
  • CHRO
  • Exchange
  • RIME NYSE
  • CHRO Nasdaq
  • Market Cap
  • RIME 4.9M
  • CHRO 4.2M
  • IPO Year
  • RIME 1994
  • CHRO 2024
  • Fundamental
  • Price
  • RIME $0.08
  • CHRO $0.64
  • Analyst Decision
  • RIME
  • CHRO Strong Buy
  • Analyst Count
  • RIME 0
  • CHRO 1
  • Target Price
  • RIME N/A
  • CHRO N/A
  • AVG Volume (30 Days)
  • RIME 93.4M
  • CHRO 164.7K
  • Earning Date
  • RIME 11-19-2024
  • CHRO 11-13-2024
  • Dividend Yield
  • RIME N/A
  • CHRO N/A
  • EPS Growth
  • RIME N/A
  • CHRO N/A
  • EPS
  • RIME N/A
  • CHRO N/A
  • Revenue
  • RIME $32,479,657.00
  • CHRO N/A
  • Revenue This Year
  • RIME N/A
  • CHRO N/A
  • Revenue Next Year
  • RIME N/A
  • CHRO N/A
  • P/E Ratio
  • RIME N/A
  • CHRO N/A
  • Revenue Growth
  • RIME 11.81
  • CHRO N/A
  • 52 Week Low
  • RIME $0.07
  • CHRO $0.45
  • 52 Week High
  • RIME $1.97
  • CHRO $6.00
  • Technical
  • Relative Strength Index (RSI)
  • RIME N/A
  • CHRO 48.09
  • Support Level
  • RIME N/A
  • CHRO $0.56
  • Resistance Level
  • RIME N/A
  • CHRO $0.69
  • Average True Range (ATR)
  • RIME 0.00
  • CHRO 0.09
  • MACD
  • RIME 0.00
  • CHRO -0.00
  • Stochastic Oscillator
  • RIME 0.00
  • CHRO 21.12

Stock Price Comparison Chart: RIME vs CHRO

RIME
CHRO
MarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember0.00.51.01.52.02.53.03.54.04.55.0RIME VS CHRO

About RIME ALGORHYTHM HOLDINGS INC

Algorhythm Holdings Inc is a holding company with two primary investments. It operates through its subsidiaries, one of which is an emerging leader in the AI-enabled global logistics industry. The other subsidiary is engaged in consumer karaoke products, Which designs and distributes the industry's widest assortment of at-home and in-car karaoke entertainment products.

About CHRO Chromocell Therapeutics Corporation

Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use